This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Agency for Science, Technology and Research, Chugai Seiyaku Kabushiki Kaisha, National University of Singapore. Active years: 2019-2025.
Company Filing History:
5 out of 1,556 
4 out of 984 
1 out of 850 
Years Active: 2019-2025
Title: Roland Zuest: Innovator in Anti-Dengue Virus Research
Introduction
Roland Zuest is a prominent inventor based in Singapore, known for his significant contributions to the field of biotechnology. He holds a total of 5 patents, focusing primarily on innovative solutions for treating viral infections, particularly dengue virus.
Latest Patents
Zuest's latest patents include groundbreaking work on anti-dengue virus antibodies and polypeptides containing variant Fc regions. These disclosures provide anti-DENV antibodies and methods for their production and application. The anti-DENV antibodies are designed to treat DENV infections effectively. Additionally, the patents cover polypeptides with a variant Fc region, which also have applications in treating viral infections. These polypeptides are characterized by a Fc variant that includes at least one amino acid alteration, resulting in decreased FcYR-binding activity while maintaining C1q-binding activity compared to the parent Fc region.
Career Highlights
Throughout his career, Zuest has worked with notable organizations such as the Agency for Science, Technology and Research and Chugai Seiyaku Kabushiki Kaisha. His work in these institutions has significantly advanced the understanding and treatment of viral infections.
Collaborations
Zuest has collaborated with esteemed colleagues, including Katja Fink and Xing'er Christine Koo, contributing to a rich exchange of ideas and innovations in his field.
Conclusion
Roland Zuest's innovative work in the development of anti-dengue virus treatments showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against viral infections, particularly dengue fever.